←
Toshiyasu Suzuki67 posts
Toshiyasu Suzuki avatar

Toshiyasu Suzuki

@ToshiM32

Junior group leader at CCII Kyoto. Cancer immunology scientist. To beat cancer.

◷ Joined March 2020▧ 8 Photos and videos
Toshiyasu Suzuki avatar
Toshiyasu Suzuki@ToshiM32·Sep 22

僕も登壇します。

学術集会3日目の9/26には、Cancer Research Career Forumの第1回「若手研究者編」を開催します。 テーマは「研究者の仕事と現実、そして未来を語ろう!」をです。経験・迷いを持ち寄りつながりを広げる場です。ぜひご来場を! #JCA85

Post attachment
日本癌学会学術総会 avatar
⟳ Toshiyasu Suzuki retweeted
日本癌学会学術総会@jca85_2026kyoto·Sep 19

学術集会3日目の9/26には、Cancer Research Career Forumの第1回「若手研究者編」を開催します。 テーマは「研究者の仕事と現実、そして未来を語ろう!」をです。経験・迷いを持ち寄りつながりを広げる場です。ぜひご来場を! #JCA85

Post attachment
Toshiyasu Suzuki avatar
Toshiyasu Suzuki@ToshiM32·Sep 22

I started a new role in Kyoto (though it's already been 6 months). Is the weather much different from Glasgow?

Post attachment
Toshiyasu Suzuki avatar
Toshiyasu Suzuki@ToshiM32·7 Mar 2025

I found this in my post box and I am very motivated by this. Our activities are made possible by your donations. Our group leader Prof Seth Coffelt has been supported by £1 million funding to conduct our reserch, and this is what your donations made possible.

Post attachmentPost attachment
Toshiyasu Suzuki avatar
Toshiyasu Suzuki@ToshiM32·5 Dec 2024

It is actually whole-body disease. Currently, little is understood but we are seeing a great progress in this field, or the view to look by the systemic effect.

EACR@EACRnews26 Nov 2024

Submit your abstract by 13 January for our upcoming virtual conference! Join us in exploring the systemic consequences of cancer: eacr.org/conference/systemic…

Post attachment
Anirban Maitra avatar
⟳ Toshiyasu Suzuki retweeted
Anirban Maitra@Aiims1742·29 Nov 2024

THE DEFINITIVE AGING ATLAS in @ScienceMagazine 🤯 A panoramic view of cell population dynamics in mammalian aging science.org/doi/10.1126/scie… PanSci, a single-cell transcriptome atlas profiling over 20 million cells from 623 mouse tissues across different life stages, sexes & genotypes

EACR avatar
⟳ Toshiyasu Suzuki retweeted
EACR@EACRnews·18 Oct 2024

Don't miss your chance to contribute to the next edition of the EACR-@AstraZeneca conference, bringing the spotlight on ctDNA! Abstract submissions close in one month on 18 November: eacr.org/conference/circulat…

0:10
Jason Sheltzer avatar
⟳ Toshiyasu Suzuki retweeted
Jason Sheltzer@JSheltzer·7 Oct 2024

Another scientist whose work initially didn't get the recognition that it deserved - Victor Ambros was denied tenure at Harvard, even after publishing the seminal work that resulted in him receiving the Nobel Prize today!

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Post attachment
Jason Sheltzer avatar
⟳ Toshiyasu Suzuki retweeted
Jason Sheltzer@JSheltzer·9 Oct 2024

John Jumper went from getting a PhD to getting a Nobel Prize in just seven years!

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”

Post attachment
John Peters avatar
⟳ Toshiyasu Suzuki retweeted
John Peters@johnthejack·27 Sep 2024

Scotland has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13. statnews.com/2024/01/25/hpv-…

EACR avatar
⟳ Toshiyasu Suzuki retweeted
EACR@EACRnews·16 May 2024

Registration is OPEN for our brand new conference, Cancer and Ageing, fostering interdisciplinary dialogue among researchers and clinicians. As always, EACR members benefit from discounted registration rates! Don't miss it: eacr.org/conference/canceran…

Post attachment